FDA InspectionEmergent BioSolutions Canada Inc.
Emergent BioSolutions Canada Inc. – FDA Inspection, May 16, 2017
Record Details
This FDA Inspection record concerns Emergent BioSolutions Canada Inc., with an inspection on May 16, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
ID · e57724ff-639b-4a70-bc27-affc7bd9b34d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1018375
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Emergent BioSolutions Canada Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 12, 2026 | Not classified | Office of Inspections and Investigations | Blood and Blood Products |
| August 27, 2025 | Not classified | Office of Inspections and Investigations | |
| September 13, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Or discuss it with
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Emergent BioSolutions Canada Inc. document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA